Equities Analysts Issue Forecasts for ELDN FY2025 Earnings
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2025 EPS estimates for Eledon Pharmaceuticals in a note issued to investors on Thursday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will post earnings per share of ($0.73) for the year, up from their […]
